Apaf-1 activators represent a distinctive class of chemical entities that modulate the function of Apaf-1, a pivotal protein in cellular homeostasis. Apaf-1, or apoptotic protease-activating factor 1, is a key component in the intrinsic apoptotic pathway, a tightly regulated cellular process responsible for eliminating damaged or unwanted cells. In the intricate landscape of apoptosis, Apaf-1 serves as a critical node, orchestrating the activation of caspases, which are central players in the execution of programmed cell death. Functionally, Apaf-1 operates as a molecular switch, integrating signals from various cellular stressors to initiate the apoptotic cascade. In response to cellular perturbations, such as DNA damage or metabolic stress, Apaf-1 undergoes a conformational change, enabling its oligomerization into a complex known as the apoptosome. This multimeric structure acts as a platform for the recruitment and activation of procaspase-9, culminating in the activation of downstream effector caspases and the eventual dismantling of the cell. The intricate interplay between Apaf-1 and other regulatory elements in the apoptotic pathway underscores its central role in maintaining cellular equilibrium.
Activators of Apaf-1 operate at the nexus of cellular signaling, where subtle perturbations can have profound implications for cell fate. These chemical entities can modulate Apaf-1 activity through various mechanisms, ranging from direct binding to allosteric regulation. By influencing the activation of Apaf-1, these compounds offer a unique vantage point for researchers to dissect the molecular intricacies of apoptosis. Exploring Apaf-1 activation sheds light on the fundamental mechanisms governing cellular fate decisions and contributes to the broader understanding of the delicate balance between cell survival and programmed cell death.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A protein kinase inhibitor that induces apoptosis via cytochrome c release, activating Apaf-1. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
An anti-cancer drug that induces DNA damage, leading to cytochrome c release and Apaf-1 activation. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Inhibits DNA topoisomerase I, causing DNA damage, cytochrome c release, and Apaf-1 activation. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $115.00 $337.00 | 3 | |
Induces mitochondrial cytochrome c release, leading to Apaf-1 activation. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $87.00 $224.00 | ||
Induces apoptosis in cancer cells by causing mitochondrial membrane permeabilization and activating Apaf-1. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $254.00 | 41 | |
Mitochondrial complex I inhibitor, leading to increased ROS, cytochrome c release, and Apaf-1 activation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Interferes with DNA function, resulting in apoptosis and the subsequent activation of Apaf-1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor that can induce ER stress, cytochrome c release, and Apaf-1 activation. | ||||||
C-8 Ceramide | 74713-59-0 | sc-205233 sc-205233A sc-205233B | 1 mg 5 mg 25 mg | $19.00 $63.00 $228.00 | 1 | |
A lipid that induces mitochondrial dysfunction, leading to cytochrome c release and Apaf-1 activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Induces ER stress leading to calcium release, mitochondrial dysfunction, cytochrome c release, and Apaf-1 activation. | ||||||